An Impactful Year for Molecular Testing in GI Cancers
Categories
The guidelines released in 2017 are going to serve as the foundation for molecular testing for all gastrointestinal (GI) cancers, says Antonia R. Sepulveda, MD, PhD.
http://www.onclive.com/web-exclusives/an-impactful-year-for-molecular-testing-in-gi-cancers